SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Obsidian Therapeutics, Inc. (OBX) News

Follow Obsidian Therapeutics, Inc. (OBX) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol OBX Asset equity Sector Markets 90 days 2 Last 11.97 Updated Sep 09, 2026, 08:45 PM UTC Open live news feed Open OBX chart & news
L Obsidian Therapeutics initiated at Outperform by William Blair William Blair initiated coverage of Obsidian Therapeutics with an Outperform rating, per Benzinga ratings actions. EQUITY | Sep 09, 2026, 08:45 PM UTC L Obsidian Therapeutics files prospectus for resale of up to 29,164,045 shares Obsidian Therapeutics filed a prospectus covering the resale of up to 29,164,045 shares of common stock by selling stockholders. REGULATION | Aug 28, 2026, 09:16 PM UTC